MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy
Diabetes, Obesity and Metabolism · 2025-04 · 27 (4) · 1888-1901
DOI: 10.1111/dom.16182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 07.01.2025. Verfasst von Jianyu Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, China-Japan Union Hospital, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Proto-Oncogene Protein c-ets-1, Diabetic Retinopathy, MicroRNAs, Endothelial Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province, Diabetes Fund of the Chinese Microcirculation Society Major Project.
Abstract (Originalsprache)
Aims
This study aimed to discover the regulatory mechanisms contributing to angiogenesis in nonproliferative diabetic retinopathy (NPDR). Materials and Methods This study employed a case–control design involving type 2 diabetes patients with and without NPDR. We utilised microRNA sequencing to analyse plasma and retina samples from T2D patients, to identify both existing and novel microRNAs relevant to retinal health. An integrative approach combining single‐cell sequencing data from mouse and rat models was used to explore the molecular mechanism in retinal cells under diabetes condition.
Results
We identified a specific set of circulating microRNAs with strong predictive potential for distinguishing NPDR patients. In addition, a novel microRNA targeting the ETS proto‐oncogene 1 (Ets1), a key regulator of microvascular angiogenesis, was found to be upregulated in the plasma of NPDR patients. Analysis of single‐cell sequencing data suggested that Ets1 expression was downregulated in diabetic endothelial cells and was associated with the repression of Angiopoietin‐1 and phosphoinositide 3‐kinase‐Akt (PI3K‐Akt) signalling pathways, indicating an anti‐angiogenic mechanism in NPDR.
Conclusions
The identification of a novel microRNA involved in the anti‐angiogenic mechanism in NPDR provides new insights into the molecular underpinnings of endothelial dysfunction in diabetic retinopathy. Our retina‐specific circulating microRNA panel has potential utility in risk assessment and early detection of NPDR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, China-Japan Union Hospital, Jilin University, Changchun, China.
- Department of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China.
- Department of Oral Biology, School and Hospital of Stomatology, Jilin University, Changchun, China.
- Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.
- Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, China.
- Department of Pathology, College of Basic Medical Sciences, Jilin University, Changchun, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jilin Province
- Diabetes Fund of the Chinese Microcirculation Society Major Project
- Jilin Provence Budgeted Basic Construction Funds
- ChangBai Mountain Scholars Program of Jilin Province
Zitieren
APA
Zhao, J., Sun, Z., Li, Z., Xu, M., Tian, A., An, Z., Guo, W., He, C., Dong, Y., Wen, J., Yang, J., Wang, Q., & Chen, P. (2025). MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy. Diabetes, Obesity and Metabolism, 27(4), 1888-1901. https://doi.org/10.1111/dom.16182
Vancouver
Zhao J, Sun Z, Li Z, Xu M, Tian A, An Z, et al. MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy. Diabetes, Obesity and Metabolism. 2025;27(4):1888-1901. doi:10.1111/dom.16182
BibTeX
@article{Zhao2025,
author = {Zhao, Jianyu and Sun, Zewen and Li, Zimeng and Xu, Mengyu and Tian, Aowen and An, Zhengwen and Guo, Wenbo and He, Chang and Dong, Ying and Wen, Jianping and Yang, Jianli and Wang, Qing and Chen, Peng},
title = {MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {4},
pages = {1888--1901},
doi = {10.1111/dom.16182}
}
EUVIMED